Mass spectrometry-based proteomics: current status and potential use in clinical chemistry.
about
A streamlined approach to high-throughput proteomics.Alteration in protein expression in estrogen receptor alpha-negative human breast cancer tissues indicates a malignant and metastatic phenotype.The emerging importance of DNA mapping and other comprehensive screening techniques, as tools to identify new drug targets and as a means of (cancer) therapy personalisation.Analysis of organelles within the nervous system: impact on brain and organelle functions.Sys-BodyFluid: a systematical database for human body fluid proteome researchMethodology and applications of disease biomarker identification in human serum."Subcellular proteomics" of neuromelanin granules isolated from the human brain.
P2860
Q33215042-0BB63064-BE50-4F6F-9AD6-BB939B21E622Q33625197-3AE1C0F3-EA56-4654-9131-D0DDC59BBCBDQ36425978-DD449190-76C3-49F8-9118-9B416569FF1CQ37157865-99F5B473-27C0-45C1-B687-899E4C07A274Q37202808-04EB9F36-6155-4389-BC1C-AF347E2066E5Q37574961-4889033C-A818-4B6E-975F-A3A82603C589Q46455513-DA2BAA62-3A27-4694-99BB-4E3D1622CC4A
P2860
Mass spectrometry-based proteomics: current status and potential use in clinical chemistry.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@ast
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@en
type
label
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@ast
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@en
prefLabel
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@ast
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@en
P2860
P356
P1476
Mass spectrometry-based proteo ...... ial use in clinical chemistry.
@en
P2093
Denis F Hochstrasser
Ron D Appel
P2860
P304
P356
10.1515/CCLM.2003.237
P577
2003-12-01T00:00:00Z